Pharmaceutics 2012, 4(4), 590-606; doi:10.3390/pharmaceutics4040590

Composition Influence on Pulmonary Delivery of Rifampicin Liposomes

1email, 1email, 1email, 2email, 1email and 1,* email
Received: 18 September 2012; in revised form: 1 November 2012 / Accepted: 16 November 2012 / Published: 27 November 2012
(This article belongs to the Special Issue Drug Delivery Using Nanotechnology)
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Abstract: The effects of lipid concentration and composition on the physicochemical properties, aerosol performance and in vitro toxicity activity of several rifampicin-loaded liposomes were investigated. To this purpose, six liposome formulations containing different amounts of soy phosphatidylcholine and hydrogenated soy phosphatidylcholine, with and without cholesterol and oleic acid, were prepared and fully characterized. Uni- or oligo-lamellar, small (~100 nm), negatively charged (~60 mV) vesicles were obtained. Lipid composition affected aerosol delivery features of liposomal rifampicin; in particular, the highest phospholipid concentration led to a better packing of the vesicular bilayers with a consequent higher nebulization stability. The retention of drug in nebulized vesicles (NER%) was higher for oleic acid containing vesicles (55% ± 1.4%) than for the other samples (~47%). A549 cells were used to evaluate intracellular drug uptake and in vitro toxicity activity of rifampicin-loaded liposomes in comparison with the free drug. Cell toxicity was more evident when oleic acid containing liposomes were used.
Keywords: liposomes; rifampicin; cholesterol; oleic acid; rheology; pulmonary delivery; aerosol; cell viability; cellular uptake
PDF Full-text Download PDF Full-Text [2277 KB, uploaded 27 November 2012 12:04 CET]

Export to BibTeX |

MDPI and ACS Style

Manca, M.L.; Sinico, C.; Maccioni, A.M.; Diez, O.; Fadda, A.M.; Manconi, M. Composition Influence on Pulmonary Delivery of Rifampicin Liposomes. Pharmaceutics 2012, 4, 590-606.

AMA Style

Manca ML, Sinico C, Maccioni AM, Diez O, Fadda AM, Manconi M. Composition Influence on Pulmonary Delivery of Rifampicin Liposomes. Pharmaceutics. 2012; 4(4):590-606.

Chicago/Turabian Style

Manca, Maria L.; Sinico, Chiara; Maccioni, Anna M.; Diez, Octavio; Fadda, Anna M.; Manconi, Maria. 2012. "Composition Influence on Pulmonary Delivery of Rifampicin Liposomes." Pharmaceutics 4, no. 4: 590-606.

Pharmaceutics EISSN 1999-4923 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert